Page 2,883«..1020..2,8822,8832,8842,885..2,8902,900..»

Category Archives: Transhuman News

COD: AW – 25 "Double DNA Bombs" of Christmas! Day 8 – CLUTCH! – Video

Posted: December 9, 2014 at 5:44 am


COD: AW - 25 "Double DNA Bombs" of Christmas! Day 8 - CLUTCH!
Hope you all enjoy the video, let me know any suggestions you have for me! Can we hit 60 likes for another commentary? Follow me - http://twitter.com/clueshh.

By: Clues

Originally posted here:
COD: AW - 25 "Double DNA Bombs" of Christmas! Day 8 - CLUTCH! - Video

Posted in DNA | Comments Off on COD: AW – 25 "Double DNA Bombs" of Christmas! Day 8 – CLUTCH! – Video

14 Casiopea & Sync DNA – Cercular Dream – Video

Posted: at 5:43 am


14 Casiopea Sync DNA - Cercular Dream

By: Randy Wihandika

Here is the original post:
14 Casiopea & Sync DNA - Cercular Dream - Video

Posted in DNA | Comments Off on 14 Casiopea & Sync DNA – Cercular Dream – Video

USB-sized DNA sequencer is error-prone, but still useful

Posted: at 5:43 am

DNA passes through a pore, the basis of nanopore sequencing.

Nearly three years ago, a company called Oxford Nanopore made waves when it announced thedevelopment of DNA sequencing technology that was simple and compact enough to fit ona USB stick. The intervening years have been filled with product delays and apparent problems with read accuracy. This morning, however, a paper is being released that relies on the technology, and while the technology still has problems, it can help provide some medically relevant information.

Most methods of studying DNA perform what's called "sequencing by synthesis." They make a new copy of the DNA strand being sequenced, keeping track of which base is added to each location. This is highly effective, but it requires the use of consumables: each base added has to be supplied to the reaction, as does the enzyme that does the adding. All of this adds to the cost of the sequencing reaction, and it places a limit on how cheap we can make the process of sequencing a genome.

Oxford Nanopore's method is fundamentally different. Instead of adding new bases, the DNA strand to be sequenced is stuffed through a protein with a hole in the middle. As each base passes through this pore, its electrical properties are read, allowing the hardware to determine which base is going by. Although the pore will have a finite lifetime, the process doesn't need any specialized chemicals or enzymes and therefore has the potential to be very cheap.

It also has the potential to read the sequence of any length of DNA molecule. The most popular DNA sequencing technology, made by Illumina, is not commonlyused toread molecules that are much longer than 100 bases long, creating what's called "short read" sequences. It makes up for the short length by reading incredibly high volumes of DNA molecules.

But high volume doesn't entirely make up for things. In many areas of genomes, there are repeated sequences that are longer than 100 bases longthings like old, disabled viruses and transposable elements that hop around the genome. If a bit of sequence ends up in one of these repetitive elements, then there's no possible way to figure out where it resides in the genome. As a result, these repetitive sequences break up any genomes constructed solely from short reads, limiting our picture of the genome.

IfOxford Nanopore could get its system up and working, there would definitely be a use for it. But three years into things, and the new paper is still describing pre-release hardware. Gone is the claim of it being an actual USB device; instead, it's now referred to as "similar in size to a USB memory stick." But the biggest problem is the error rate; the system gets nearly a third of the bases it sequences wrong.

That may sound pretty useless, but it's not as bad as it seems. If both strands of the DNA molecule happen to be read, then accuracy gets bumped up to over 80 percent. And when combined with short-read Illumina data, it's possible to use it to help build more complete genomes.

The basic idea is that the long reads of the nanopore system can provide a scaffold for the entire genomeone that's error-filled but puts everything in the right order. The high-accuracy short reads from traditional sequencing methods can then fill in the scaffold with accurate data. The authors test this by sequencing a multidrug-resistant Salmonella strain. The drug resistance genes, in this case, were surrounded by repetitive DNA, leaving it unclear whether they were in the bacteria's genome at all, much less where they might be located.

In general, the approach of using both methods worked well. The number of gaps and unordered sequences went down, and a cluster of antibiotic resistance genes was identified in the regular chromosome of this strain. It wasn't entirely without problems, though. It turns out Illumina machines have problems when there are lots of G's and C's in a sequence, so there were a few areas that continued to be low quality. But the end result was a clearer picture of a medically relevant bacterial strain.

Read the original post:
USB-sized DNA sequencer is error-prone, but still useful

Posted in DNA | Comments Off on USB-sized DNA sequencer is error-prone, but still useful

Ancient DNA on parchments can reveal agricultural development

Posted: at 5:43 am

A new technique to analyse DNA found in millions of ancient parchments (material made from animal skin) stored in archives can help scientists trace agricultural development across the centuries, according to researchers.

Thanks to increasingly progressive genetic sequencing techniques, the all-important historical tales these documents tell are no longer confined to their texts.

The vital information also comes from the DNA of the parchment on which they are written, say researchers from Trinity College Dublin and the University of York.

"Parchments are an amazing resource for genetic studies that consider agricultural development over the centuries. There must be millions stored away in libraries, archives, solicitors' offices and even in our own attics," said Daniel Bradley, a professor of population genetics at Trinity College Dublin.

Parchment was the writing material of choice for thousands of years, going back to the Dead Sea scrolls.

For the study, the team used state-of-the-art scientific techniques to extract ancient DNA and protein from tiny samples of parchment from documents from the late 17th and late 18th centuries.

The resulting information enabled them to establish the type of animals from which the parchment was made.

Geneticists at Trinity extracted DNA from two tiny samples of parchment.

Meanwhile, researchers at University of York extracted collagen (protein) from the same parchment samples.

The first sample showed a strong affinity with northern Britain, specifically the region in which black-faced breeds such as Swaledale, Rough Fell and Scottish Blackface are common.

Continued here:
Ancient DNA on parchments can reveal agricultural development

Posted in DNA | Comments Off on Ancient DNA on parchments can reveal agricultural development

Deal Brings Genome Data to BlackBerry Passport

Posted: at 5:43 am

With the NantOmics Cancer Genome Browser, doctors can look up information about patients' genetic data.

IBM and Google aren't the only ones attempting to cure cancer: BlackBerry and NantHealth are partnering to give doctors simplified access to genetic data.

Specifically, the firms revealed a secure browser for the BlackBerry Passport, dubbed the NantOmics Cancer Genome Browser, which doctors can use to look up information about patients' genetic data, as well as relevant treatment options.

According to BlackBerry, doctors will be able to examine a patient's chromosomes at an individual base-pair level. The human genome contains approximately 3 billion of these base pairs.

"BlackBerry's partnership with NantHealth illustrates how the mobile security and collaboration technology we are known for can be reimagined to create revolutionary applications across a variety of industries," BlackBerry CEO John Chen said in a statement.

The Canadian manufacturer introduced its 4.5-inch square handset in September. It sports a physical QWERTY keyboard and 1,440-by-1,440 display.

"BlackBerry technology has proven itself secure, reliable and powerful enough to be counted on in life-and-death situations," Chen said. "Its innovative form and functionality make BlackBerry Passport an ideal addition to a doctor's medical kit."

The service works with NantHealth's Eviti treatment recommendation engine to help personalize protocols for individual patients.

"NantHealth has quietly built the unique capability of placing a supercomputer into the doctor's hand at point of care and in time of need," NantHealth CEO Patrick Soon-Shiong said. "Now with BlackBerry's partnership and through the power of the cloud and secure networks, the reality is we are now able to put dozens of supercomputers, through mobile devices, into doctor's hands on a global basis. Our goal is to extend this unique capability from doctor to patient, thereby establishing patient-empowered 21st century health."

The NantOmics Cancer Genome Browser will be on display at January's Consumer Electronics Show in Las Vegas, and will be preloaded on some BlackBerry Passport devices and available to professionals in early 2015.

Read the original post:
Deal Brings Genome Data to BlackBerry Passport

Posted in Genome | Comments Off on Deal Brings Genome Data to BlackBerry Passport

Your Guide To Treat Your Childs Eczema – Video

Posted: at 5:42 am


Your Guide To Treat Your Childs Eczema
Great treatment for your infants or childs eczema. Get more info by clicking the link below: http://tinyurl.com/onvy797.

By: Tlw 4service

Read the original:
Your Guide To Treat Your Childs Eczema - Video

Posted in Eczema | Comments Off on Your Guide To Treat Your Childs Eczema – Video

Whats Going Around Eczema

Posted: at 5:42 am

By Dr. Kyle Scarborough / Whats Going Around

Eczema, from the Greek for boil out is a term that encompasses a wide variety of skin conditions. Causes are equally complex. Skin allergies to food, detergents and even dust mites are suspected. It may be inherited, especially among allergy sufferers. Xerotic eczema flares up in the cold weather we are starting to experience.

Signs and symptoms: As the name implies, these skin conditions usually start as small, blister-like lesions that start to spread over the skin, causing red, dry, scaly patches on any part of the body. Itching and flaking are very common. Left untreated, the affected skin can become infected with staph.

What to do: There is no cure, but symptoms can usually be controlled with moisturizers and steroid creams. Persistent cases may require stronger prescription steroids. Those intolerant of steroids may benefit from other immunosuppressive agents, but side effects are more of an issue. Mild soaps and detergents for sensitive skin are widely available. Avoid wearing cloth that can irritate the skin.

Thought for the day: Dry, flaky, itchy skin could be eczema setting in.

Whats Going Around is contributed by family practice doctor Kyle Scarborough, M.D. You can reach him at drscarborough@familylifemedical.com.

Original post:
Whats Going Around Eczema

Posted in Eczema | Comments Off on Whats Going Around Eczema

Psoriasis Free For Life Program | Amazing Psoriasis Free For Life Program By Katy Wilson – Video

Posted: at 5:42 am


Psoriasis Free For Life Program | Amazing Psoriasis Free For Life Program By Katy Wilson
http://www.tinyurl.com/psoriasisfreeforlifenow Psoriasis Free For Life Program: Psoriasis Free for Life is an effective method written by Katy Wilson, who is an alternative Medical Practitioner...

By: Leti Castle

Here is the original post:
Psoriasis Free For Life Program | Amazing Psoriasis Free For Life Program By Katy Wilson - Video

Posted in Psoriasis | Comments Off on Psoriasis Free For Life Program | Amazing Psoriasis Free For Life Program By Katy Wilson – Video

Psoriasis Revolution and Discount Link – Video

Posted: at 5:42 am


Psoriasis Revolution and Discount Link
Discount Link http://www.psoriasisrevolutionpdf.com/-Psoriasis-Revolution- About the Book Psoriasis Revolution is a well-written book that carefully describe...

By: Psoriasis Revolution

Original post:
Psoriasis Revolution and Discount Link - Video

Posted in Psoriasis | Comments Off on Psoriasis Revolution and Discount Link – Video

New approach for treating Alzheimer's disease: Psoriasis drug

Posted: at 5:42 am

It is estimated that about 35 million people worldwide currently suffer from dementia and it is expected that the number will increase to 135 million by the year 2050. The disease is already one of the most common health problems in the elderly, which is why experts predict that the numbers of people affected will increase over time. Researchers at the Department of Psychiatry and Psychotherapy of the University Medical Center of Johannes Gutenberg University Mainz (JGU) have recently gained new insights into how it may in future be possible to treat patients with the currently most common form of dementia, Alzheimer's disease. It seems that a drug that is actually approved for treatment of the dermal disorder psoriasis stimulates the activity of the enzyme ADAM10 in the brain of Alzheimer's patients. There is already good evidence from basic research that this enzyme should be capable of suppressing Alzheimer's disease-related effects such as impaired cerebral function and that it thus might improve learning and memory capacity in patients. The results of the related study have recently been published in the journal Neurology.

According to estimates of the German Alzheimer's Association (DAlzG), approximately 1.5 million dementia patients currently live in Germany. Some 1 to 1.2 million of these suffer from Alzheimer's. Medicine is currently only able to treat the symptoms of the disease and delay its progress and thus also the need for increased nursing care. No curative therapy has yet been developed. This means that Alzheimer's disease remains one of the biggest challenges to modern medicine and is an important field for research.

There is still no consensus on what triggers the most common form of the disease, late-onset Alzheimer's. However, it is generally accepted that the activity of certain enzymes called secretases plays a role here. These enzymes cleave proteins on cell membranes, releasing the products of this cleavage process into the extracellular space. What happens in Alzheimer's is that there is increased cleavage of the amyloid precursor protein by beta-secretase, leading to the formation of amyloid-beta peptides. These peptides aggregate, damage nerve cells, and are the main component of the so-called Alzheimer's plaques that accumulate in the brains of patients. The alpha-secretase ADAM10 is a competitor of beta-secretase. It cleaves the amyloid precursor protein in such a way that the synthesis of amyloid beta-peptides is prevented while the growth factor APPs-alpha, which protects nerve cells, is released.

Taking this information as their starting point, Dr. Kristina Endres and Professor Falk Fahrenholz of the Department of Psychiatry and Psychotherapy of the Mainz University Medical Center have decided to take a new approach to the treatment of Alzheimer's. Working in collaboration with Professor Klaus Lieb and Professor Andreas Fellgiebel, both also working at the Department of Psychiatry and Psychotherapy, and with the cooperation of Professor Stefan Teipel and his team at the German Center for Neurodegenerative Diseases (DZNE) in Rostock, the researchers have demonstrated that oral administration of a psoriasis medication in a group of Alzheimer's patients results in elevated levels of APPs-alpha in their spinal fluid. This is interpreted as a stimulation of the activity of the alpha-secretase ADAM10, which in turn would result in the reduced accumulation of Alzheimer's plaques. In animal models of Alzheimer's disease, it has also been shown that ADAM10 enhances learning and memory capacity. The medication was well-tolerated by the patients. In order to further investigate the effect of the test substance on cognitive performance and to establish whether it can be used as a long-term treatment for Alzheimer's patients, larger clinical trials in which the substance is administered for longer periods will need to be undertaken.

Story Source:

The above story is based on materials provided by Johannes Gutenberg Universitaet Mainz. Note: Materials may be edited for content and length.

View original post here:
New approach for treating Alzheimer's disease: Psoriasis drug

Posted in Psoriasis | Comments Off on New approach for treating Alzheimer's disease: Psoriasis drug

Page 2,883«..1020..2,8822,8832,8842,885..2,8902,900..»